Volume 12, Issue 3 (12-2024)
jmsthums 2024, 12(3): 13-26 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
P A, H R J, M T. Comparing the effectiveness of cognitive-behavioral therapy with narrative therapy on fatigue and health anxiety in patients with MS. jmsthums 2024; 12 (3) :13-26
URL: http://jms.thums.ac.ir/article-1-1304-en.html
URL: http://jms.thums.ac.ir/article-1-1304-en.html
1- Islamic Azad University Najafabad
2- Islamic Azad University of Najafabad
3- Sadjad University Mashhad
2- Islamic Azad University of Najafabad
3- Sadjad University Mashhad
Abstract: (139 Views)
Background & Aim: Fatigue and anxiety are two significant complications thatgreatly impact the life quality for individuals with Multiple Sclerosis (MS). The purpose of this study was to assess the effectiveness of cognitive-behavioral therapyand narrative therapy in reducing health anxiety and fatigue among MS patients in Tehran.
Methods: This semi-experimental study utilized a pre-test-post-test type and follow-up method to examine the effects of a treatment on 45 patients with multiple sclerosis. The participants were selected through a purposive sampling method at the Empowerment Charity in Tehran in 2023. Two groups received cognitive-behavioral therapy and narrative therapy interventions while the control group did not receive treatment. The research tools included Salkovskis's (2000) health anxiety questionnaire and Krupp's (1989) fatigue questionnaire. Data analysis was performed using statistical analysis of variance with repeated measurements.
Results: The results showed that both cognitive-behavioral therapy and narrative therapy were effective on health anxiety and fatigue in patients with Multiple Sclerosis. The effect size for these therapies was 0.194 and 0.665 respectively, with a significance level of 0.001. Additionally, narrative therapy in reducing fatigue was significantly greater than that of cognitive-behavioral therapy (P<0.01).
Conclusion: It appears that cognitive-behavioral therapy and narrative therapy can serve as effective complementary treatments for Multiple Sclerosis patients in addition to other treatment methods.
Methods: This semi-experimental study utilized a pre-test-post-test type and follow-up method to examine the effects of a treatment on 45 patients with multiple sclerosis. The participants were selected through a purposive sampling method at the Empowerment Charity in Tehran in 2023. Two groups received cognitive-behavioral therapy and narrative therapy interventions while the control group did not receive treatment. The research tools included Salkovskis's (2000) health anxiety questionnaire and Krupp's (1989) fatigue questionnaire. Data analysis was performed using statistical analysis of variance with repeated measurements.
Results: The results showed that both cognitive-behavioral therapy and narrative therapy were effective on health anxiety and fatigue in patients with Multiple Sclerosis. The effect size for these therapies was 0.194 and 0.665 respectively, with a significance level of 0.001. Additionally, narrative therapy in reducing fatigue was significantly greater than that of cognitive-behavioral therapy (P<0.01).
Conclusion: It appears that cognitive-behavioral therapy and narrative therapy can serve as effective complementary treatments for Multiple Sclerosis patients in addition to other treatment methods.
Keywords: Cognitive-behavioral therapy, narrative therapy, health-related anxiety, fatigue, multiple sclerosis.
Type of Study: Research |
Subject:
Special
Received: 2024/06/12 | Accepted: 2024/11/9 | Published: 2025/01/5
Received: 2024/06/12 | Accepted: 2024/11/9 | Published: 2025/01/5
References
1. Amin M, Hersh CM. Updates and advances in multiple sclerosis neurotherapeutics. Neurodegenerative disease management. 2023; 13(1): 47-70. [DOI:10.2217/nmt-2021-0058]
2. Emilio Portaccioa E, et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. The Lancet Regional Health - Europe, 2024; 44: 100977 2023. [DOI:10.1016/j.lanepe.2024.100977]
3. World Health Organization. Multiple Sclerosis Fact Sheet. 2023.
4. Amini P, et al. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol, 2021; 21: 235. [DOI:10.1186/s12883-021-02281-x]
5. Mohr DC, Pelletier D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain, behavior, and immunity. 2006;20(1):27-36. [DOI:10.1016/j.bbi.2005.03.011]
6. Lerdal A, Gulowsen Celius E, Krupp L, Dahl AA. A prospective study of patterns of fatigue in multiple sclerosis. European journal of neurology. 2007;14(12):1338-43. [DOI:10.1111/j.1468-1331.2007.01974.x]
7. Grossman, P., Kollhorst, B., Fliege, H., Kullowatz, A., & Krohn-Grimberghe, B. (2023). Neuropsychiatric implications of fatigue in multiple sclerosis. Journal of Neurology, 270(5), 1321-1332.
8. Yang T-t, Wang L, Deng X-y, Yu G. Pharmacological treatments for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. Journal of the neurological sciences. 2017;380:25661. [DOI:10.1016/j.jns.2017.07.042]
9. MS Foundation. Coping with anxiety in multiple sclerosis, 2023. Available at: https://msfocus.org
10. Altıntaş M, Korkut S. Investigation of coronavirus anxiety, health anxiety, and anxiety symptom levels in vertigo patients during COVID-19 pandemic. Brazilian Journal of Otorhinolaryngology. 2023;89(2):313-20. [DOI:10.1016/j.bjorl.2022.11.003]
11. Diamond PR, Dysch L, Daniels J. Health anxiety in stroke survivors: a cross-sectional study on the prevalence of health anxiety in stroke survivors and its impact on quality of life. Disability and Rehabilitation. 2023;45(1):27-33. [DOI:10.1080/09638288.2021.2022778]
12. Mansouri Koryani R, Bassak Nejad S, Mehrabizadeh Honarmand M, Majdinasab N. Effectiveness of Compassion Focused Acceptance and Commitment Therapy on Psychological Flexibility and Psychological Distress in Patients With Multiple Sclerosis. Iranian Journal of Psychiatry and Clinical Psychology. 2022;28(2):222-35. [DOI:10.32598/ijpcp.28.2.3747.1]
13. Aboutalebi H, Yazdchi N, Smkhani Akbarinejhad H. Effectiveness of compassion-focused therapy on death anxiety and quality of life among women with multiple sclerosis. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2022; 32 (1): 101-92. [DOI:10.52547/iau.32.1.92]
14. Khanali Lou R, Lotfi Kashani F. The effectiveness of cognitive-behavioral therapy on depression and its resulting dysfunctional concerns in multiple sclerosis. Islamic Life Journal. 2020;3:163-72.
15. Shareh H, Robati Z. Effect of Cognitive-Behavioral Group Therapy on Pain Self-efficacy, Fatigue, Life Expectancy and Depression in Patients With Multiple Sclerosis: A Randomized Controlled Clinical Trial. IJPCP 2021; 26 (4) :418-431. [DOI:10.32598/ijpcp.26.3.225.11]
16. Maghsoudloo F, Sanagouye Moharer G, Shirazi M. Effectiveness of Cognitive Behavioral Therapy in Reducing Anxiety Thoughts and Life Expectancy in Women with MS. RJMS 2023; 30 (1) :206-221
17. Gay MC, Cassedanne F, Barbot F, Vaugier I, Thomas S, Manchon E, et al. Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care. Journal of Neurology, Neurosurgery & Psychiatry. 2024;95(2):158-66. [DOI:10.1136/jnnp-2023-331537]
18. Zarotti N, Eccles F, Broyd A, Longinotti C, Mobley A, Simpson J. Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review. Disability and Rehabilitation. 2023; 45(10): 1720-35. [DOI:10.1080/09638288.2022.2069292]
19. Ehde DM, Alschuler KN, Day MA, Ciol MA, Kaylor ML, Altman JK, et al. Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol. Trials. 2019;20: 1-12. [DOI:10.1186/s13063-019-3761-1]
20. Wever C. Beyond psychological truth deconstructing western deficit-oriented psychology and the co-construction of alternative psychologies in narrative practice. International Journal of Narrative Therapy & Community Work. 2015(1):11-25.
21. Soghari Karbalai Herfteh FaNF, Abbas and Deljooi Sarkesh, Zahra. Comparison of the effect of narrative therapy and commitment and acceptance based therapy (ACT) on body image concerns in multiple sclerosis (MS). First National Conference on Futurology Educational Sciences and Psychology, Shiraz. 2023.
22. Banisafar A, Ahi Q, Mansouri A, Bahreynian A. Investigating the effectiveness of narrative therapy on resilience and emotional regulation of cancer patients with low psychological toughness. Journal of Psychological Science. 2024;23(133):183-95.
23. Zolfalipormaleki S, Gamari Kivi H, Rezai Sharif A. Effectiveness of Narrative Therapy on Social Physique Anxiety in Obese and Overweight Women. Journal of Ardabil University of Medical Sciences. 2023;23(3): 91-278. [DOI:10.61186/jarums.23.3.278]
24. Fazeli N, Soleimani Farsani S, Vakili Y, Ilanloo H. The Effectiveness of Narrative Therapy on Psychological Capital and a Sense of Coherence among Spouses of Individuals Undergoing Withdrawal. Scientific Quarterly Research on Addiction. 2022; 16(64): 218-197. [DOI:10.52547/etiadpajohi.16.64.197]
25. Geng C, Zhang M, Zhang L, Yin H, Wang S. Effects of Narrative Exposure Therapy for Treating Depressive and Anxious Disorders: A Systematic Review and Meta-Analysis. Psychiatry Investigation. 2024;21(4):329. [DOI:10.30773/pi.2023.0281]
26. Ya-Yi Z, Xiao-Juan L, Ming-Yu L, Xue-Ping G, Ling-Zhi H. Intervention effect of narrative therapy on non-suicidal self-injury in adolescents with depressive disorder: a prospective randomized controlled study. Chinese Journal of Contemporary Pediatrics. 2024;26(2).
27. Delavar A. educational and psychologycal Research, 4th edition, Virayesh publication institute.2023.
28. SHAHVARUGHI FA, Azimian M, Fallahpour M, Karimlou M. Evaluation of reliability and validity of the Persian version of Fatigue Severity Scale (FSS) among persons with multiple sclerosis. 2013.
29. Nargesi F, Izadi F, Kariminejad K, Rezaii Sharif A. The investigation of the reliability and validity of Persian version of Health anxiety questionnaire in students of Lorestan University of Medical Sciences. Quarterly of Educational Measurement. 2017;7(27):147-60.
30. Röttgering JG, Douw L, de Witt Hamer PC, Kouwenhoven MC, Würdinger T, van de Ven PM, et al. Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy. Trials. 2022;23(1):568. [DOI:10.1186/s13063-022-06485-5]
31. Chen T, Wang R, Zhan Y, Ma X, Sun C, Li L. Effect of Narrative Therapy on the Psychological Status and Life Quality of Family Caregivers of Adolescents with First-episode Depression. Medicinal Plant. 2022;13(6):72-84.
Send email to the article author
| Rights and permissions | |
 | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution 4.0 International License.
Designed & Developed by : Yektaweb